The World Congress on Alternatives and Animal Use in the Life Sciences ↗ is a leading international event dedicated to advancing alternatives to animal testing in research and education. Bringing together scientists, researchers, policymakers, and industry professionals, the congress provides a vital platform for knowledge exchange, best practice sharing, and discussions on cutting-edge developments in the field. 

The congress covers a wide range of topics, including alternative method development and validation, ethical considerations, regulatory frameworks, and the application of alternative approaches in toxicology, biomedical research, and education. By fostering collaboration, this event plays a crucial role in accelerating progress toward the 3Rs principles—Replacement, Reduction, and Refinement—shaping the future of scientific research and policy. 

The Scientific Program ↗ will cover key topics, including: 

• Animal Health
• Environmental Health
• Education
• One Health / Harmonization / Technologies
• Human Health – Reduction, Refinement, and Other Considerations
• Human Health – Policy
• Human Health – Replacement 

PARC will contribute to the event with following presentations: 

• Establishment of Readiness Criteria for AI-Based Tools for Risk Assessment: READYAI" Presented by Joyce de Paula Souza ↗ (University of Basel ↗, Switzerland) 

• A combined in vitro and in silico strategy to predict toxicokinetics of emerging mycotoxins. Presented by Blandine Descamps ↗ and Georg Aichinger ↗  (ETH Zurich ↗, Switzerland)

• Developing and designing INVITES-IN; a tool for assessing the internal validity of in vitro studies Presented by Gro Mathisen ↗ (Norwegian Scientific Committee for Food and Environment ↗, Norway)

• 3D spheroids for genotoxicity assessment Presented by  Marc Audebert ↗ - Invited speaker (INRAE ↗, France)

• Tackling sex bias in next generation risk assessment with women-specific physiologically based kinetic modelling Presented by Georg Aichinger ↗ (ETH Zürich, Switzerland ↗)

• AOP-based IATAs to stimulate the use of NAMs: genotoxicity as a case study Presented by Birgit Mertens ↗, (Sciensano ↗, Belgium)

We invite researchers, policymakers, and professionals from various scientific fields to join this prestigious congress and contribute to shaping the future of alternatives in life sciences.